FdaApplication
NDA 017493
Identifiers
- fda_app_no: NDA017493
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 1982-10-15 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RENAMIN W/O ELECTROLYTES | AMINO ACIDS | 6.5% (6.5GM/100ML) | INJECTABLE;INJECTION |
| TRAVASOL 10% W/O ELECTROLYTES | AMINO ACIDS | 10% (10GM/100ML) | INJECTABLE;INJECTION |
| TRAVASOL 3.5% W/ ELECTROLYTES | AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE | 3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100ML | INJECTABLE;INJECTION |
| TRAVASOL 5.5% W/ ELECTROLYTES | AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE | 5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100ML | INJECTABLE;INJECTION |
| TRAVASOL 5.5% W/O ELECTROLYTES | AMINO ACIDS | 5.5% (5.5GM/100ML) | INJECTABLE;INJECTION |
| TRAVASOL 8.5% W/ ELECTROLYTES | AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE | 8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100ML | INJECTABLE;INJECTION |
| TRAVASOL 8.5% W/O ELECTROLYTES | AMINO ACIDS | 8.5% (8.5GM/100ML) | INJECTABLE;INJECTION |
7 products